-
Yet, despite this fantastic success rate, kids are now in danger of facing this disease without this life saving drug all because manufacturing the medicine is no longer as profitable for the pharmaceutical companies as it once was.
FORBES: Proof Of The Failure Of Free Markets In Medicine
-
We're going to follow-up on this story about pharmaceutical labeling with someone from the Institute for Safe Medicine Practices.
NPR: Facing Fire, Obama to Give Speech on Race
-
The reality is that medicine is not so simple that we can just say all pharmaceutical marketing is bad.
FORBES: Pens Vs. Payments In Pharmaceutical Marketing
-
"This study provided valuable information on ancient medical and pharmaceutical practices and on the development of pharmacology and medicine over the centuries, " the researchers said.
MSN: Shipwreck yields 2,000-year-old eye pills - Technology & science - Science - LiveScience | NBC News
-
This trend is especially pronounced in India, where many top pharmaceutical companies are conducting clinical trials with measured doses of Ayurvedic medicine.
CNN: SPECIAL REPORT: HEALTH
-
Pharmaceutical companies spend hundreds of millions of dollars in bringing a new medicine to market.
FORBES: Magazine Article
-
Historically, scale for good in the pharmaceutical sector would have been based on the development and sale of medicine.
FORBES: What's Your Scale For Good?
-
Pharmaceutical companies looking to mine Big Data for insights into breakthrough opportunities in personalized medicine realize that time is their enemy and speed is their ally.
FORBES: OracleVoice: You Can Get A Chip Slower Than The New Sparc T5, You Just Have To Pay More
-
Some lawmakers have been complaining that pharmaceutical companies benefit from Medicare Part D while seniors have to choose between buying medicine and food since the drug benefit passed in 2003.
FORBES: Senior Citizens Will Pay Dearly For Health Care Price Controls
-
The agency regulates pharmaceutical products but does not have a mandate to intervene in what is called "the practice of medicine"--that is, what doctors choose to do with approved products.
FORBES: Magazine Article
-
Seeing that pharmaceutical marketing executives are evidently undeterred by the law, Dr. Angell, a senior lecturer in social medicine at Harvard Medical School and former editor in chief of The New England Journal of Medicine, advocates a prohibition on prescribing psychoactive drugs off-label.
FORBES: Bad Side-Effects Ahead For Pharma?